May 16, 2023
Life Sciences | Tea Leaves
  • CVS Health is closing down its clinical trials arm just two years after its launch. The company began its collaboration with pharmaceutical companies in 2021 and will shut it down at the end of 2024. To date,CVS Health¬†has worked with more than 30 drugmakers on 50 phase II, II and IV studies involving 33,000 participants. The clinical trial division is not aligned with CVS Health’s long-term strategy, a spokesperson wrote in an email Monday. The company declined to make an executive available for an interview. (Articles here and here)